RMD ResMed Inc

$293.62

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About ResMed Inc

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Website: https://www.resmed.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
June
CIK
943819
Address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, US
Valuation
Market Cap
$31.27B
P/E Ratio
25.14
PEG Ratio
1.39
Price to Book
5.95
Performance
EPS
$8.47
Dividend Yield
1.00%
Profit Margin
25.40%
ROE
25.70%
Technicals
50D MA
$224.84
200D MA
$231.53
52W High
$262.46
52W Low
$176.89
Fundamentals
Shares Outstanding
147M
Target Price
$266.15
Beta
0.76

RMD EPS Estimates vs Actual

● Estimated
● Actual

RMD News & Sentiment

Aug 20, 2025 • Benzinga SOMEWHAT-BULLISH
AI in Remote Patient Monitoring ( RPM ) Market to Reach USD 8,438.5 Million by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- The global AI in remote patient monitoring market, valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 and is projected to advance at a resilient CAGR of 27.5% from 2024 to 2030, culminating in a forecasted valuation of ...
Aug 18, 2025 • GlobeNewswire BULLISH
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
SAN DIEGO, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Resmed ( NYSE: RMD, ASX: RMD ) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also announced that board member Rich Sulpizio is thanked for two decades of contributions to Resmed, ...
Aug 18, 2025 • Benzinga BULLISH
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio - ResMed ( NYSE:RMD )
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a focus on digital innovation
Aug 15, 2025 • Zacks Commentary BULLISH
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
Aug 13, 2025 • Zacks Commentary BULLISH
Why ResMed ( RMD ) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Aug 11, 2025 • Zacks Commentary BULLISH
Why ResMed ( RMD ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sentiment Snapshot

Average Sentiment Score:

0.296
50 articles with scored sentiment

Overall Sentiment:

Bullish

RMD Reported Earnings

Apr 23, 2025
Mar 31, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $2.37
  • Estimate: $2.36
  • Whisper: —
  • Surprise %: 0.4%
Jan 22, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $2.43
  • Estimate: $2.32
  • Whisper: —
  • Surprise %: 4.7%
Oct 24, 2024
Sep 30, 2024 (Post market)
0.16 Surprise
  • Reported EPS: $2.20
  • Estimate: $2.04
  • Whisper: —
  • Surprise %: 7.8%
Aug 01, 2024
Jun 30, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $2.08
  • Estimate: $2.07
  • Whisper: —
  • Surprise %: 0.5%
Apr 25, 2024
Mar 31, 2024 (Post market)
0.22 Surprise
  • Reported EPS: $2.13
  • Estimate: $1.91
  • Whisper: —
  • Surprise %: 11.5%
Jan 24, 2024
Dec 31, 2023 (Post market)
0.08 Surprise
  • Reported EPS: $1.88
  • Estimate: $1.80
  • Whisper: —
  • Surprise %: 4.4%
Oct 26, 2023
Sep 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $1.64
  • Estimate: $1.62
  • Whisper: —
  • Surprise %: 1.2%
Aug 03, 2023
Jun 30, 2023 (Post market)
-0.09 Surprise
  • Reported EPS: $1.60
  • Estimate: $1.69
  • Whisper: —
  • Surprise %: -5.3%
Apr 27, 2023
Mar 31, 2023 (Post market)
0.09 Surprise
  • Reported EPS: $1.68
  • Estimate: $1.59
  • Whisper: —
  • Surprise %: 5.7%

Financials